Exhibit 10.2

 

CHANGE OF CONTROL AGREEMENT

 

THIS CHANGE OF CONTROL AGREEMENT (this “Agreement”) by and between HemaCare
Corporation., a California corporation (the “Company”) and Robert Chilton (the
“Executive”), is dated as of this 6th day of June, 2005.

 

The Board of Directors of the Company (the “Board”) has determined that it is in
the best interests of the Company and its shareholders to assure that the
Company will have the continued dedication of the Executive, notwithstanding the
possibility, threat or occurrence of a Change of Control (as defined in
Section 2 below) of the Company.  The Board believes it is imperative to
diminish the inevitable distraction of the Executive by virtue of the personal
uncertainties and risks created by a pending or threatened Change of Control and
to encourage the Executive’s full attention and dedication to the Company
currently and in the event of any threatened or pending Change of Control, and
to provide the Executive with compensation and benefits arrangements upon a
Change of Control which ensure that the compensation and benefits expectations
of the Executive will be satisfied and which are competitive with those of other
corporations.  Therefore, in order to accomplish these objectives, the Board has
caused the Company to enter into this Agreement.

 

NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS:

 

1.                                       Definitions.

 

(a)                                  “Cause” shall mean a willful act by you
which constitutes Gross Misconduct and which had or will have a material
injurious effect on the Company’s business or reputation.

 

(b)                                 The “Change of Control Period” shall mean
the period commencing upon Change of Control and ending on the first anniversary
of the date thereof.

 

(c)                                  The Executive shall be deemed to be
“Constructively Terminated” if during the Change of Control Period, (i) the
Executive’s position (including status, offices, titles and reporting
requirements), authority, duties and responsibilities are not at least
commensurate in all material respects with the most significant of those held,
exercised and assigned at any time during the one hundred twenty (120) day
period immediately preceding the Change of Control, (ii)  the Executive’s annual
base salary and bonus compensation is reduced by more than five percent (5%),
unless such reduction is part of a uniformly applied program of reductions
reasonably adopted by the Board due to the Company’s then business condition,
(iii) the Executive’s services are required to be performed at a location
greater than thirty five (35) miles from the location where the Executive was
employed immediately preceding the Effective Date or (iv) the Executive is
required to engage in a substantially increased amount of travel on Company
business.

 

1

--------------------------------------------------------------------------------

 

(d)                                 “Date of Termination” shall mean the date on
which Executive’s employment with the Company is terminated or Constructively
Terminated by reason of a Change of Control that occurs during the Change of
Control Period.

 

(e)                                  “Disability” shall mean that, at the time
your employment is terminated, you have been unable to perform the duties of
your position for a period of one hundred eighty (180) consecutive days as the
result of your incapacity due to physical or mental illness.

 

(f)                                    The “Effective Date” shall mean the first
date during the Change of Control Period on which a Change of Control occurs. 
Anything in this Agreement to the contrary notwithstanding, if a Change of
Control occurs and if the Executive’s employment with the Company is terminated
prior to the date on which the Change of Control occurs, and if it is reasonably
demonstrated by the Executive that such termination of employment (i) was at the
request of a third party who has taken steps reasonably calculated to effect a
Change of Control or (ii) otherwise arose in connection with or anticipation of
a Change of Control, then for all purposes of this Agreement the “Effective
Date” shall mean the date immediately prior to the date of such termination of
employment.

 

(g)                                 “Gross Misconduct” shall mean (i) theft or
damage of Company property, (ii) use, possession, sale or distribution of
illegal drugs, (iii) being under the influence of alcohol or drugs (except to
the extent medically prescribed) while on duty or on Company premises,
(iv) improper disclosure of confidential information, (v) conduct endangering,
or likely to endanger, the health or safety of another employee or
(vi) falsifying or misrepresenting information on Company records.

 

2.                                       Change of Control.  For the purpose of
this Agreement, a “Change of Control” shall mean:

 

(a)                                  The acquisition by any individual, entity
or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”) of
beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
Exchange Act) of thirty percent (30%) or more of either (i) the then outstanding
shares of common stock of the Company (the “Outstanding Company Common Stock”)
or (ii) the combined voting power of the then outstanding voting securities of
the Company entitled to vote generally in the election of directors (the
“Outstanding Company Voting Securities”); provided, however, that for purposes
of this subsection (a), the following acquisitions of stock shall not constitute
a Change of Control:  (i) any acquisition directly from the Company, (ii) any
acquisition by the Company, (iii) any acquisition by any employee benefit plan
(or related trust) sponsored or maintained by the Company or any corporation
controlled by the Company, (iv) any transaction, the sole purpose of which is to
change the state of incorporation or (v) any acquisition by any corporation
pursuant to a transaction which complies with clauses (i), (ii) and (iii) of
subsection (c) of this Section 2;

 

2

--------------------------------------------------------------------------------

 

(b)                                 Individuals who, as of the date hereof,
constitute the Board (the “Incumbent Board”) cease for any reason to constitute
at least a majority of the Board; provided, however, that any individual
becoming a director subsequent to the date hereof whose election, or nomination
for election by the Company’s shareholders, was approved by a vote of at least a
majority of the directors then comprising the Incumbent Board shall be
considered as though such individual were a member of the Incumbent Board, but
excluding, for this purpose, any such individual whose initial assumption of
office occurs as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents by or on behalf of a Person other than the
Board; or

 

(c)                                  Consummation of a reorganization, merger or
consolidation or sale or other disposition of all or substantially all of the
assets of the Company (a “Business Combination”), in each case, unless,
following such Business Combination, (i) all or substantially all of the
individuals and entities who were the beneficial owners, respectively, of the
Outstanding Company Common Stock and Outstanding Company Voting Securities
immediately prior to such Business Combination beneficially own, directly or
indirectly, more than sixty percent (60%) of, respectively, the then outstanding
shares of common stock and the combined voting power of the then outstanding
voting securities entitled to vote generally in the election of directors, as
the case may be, of the corporation resulting from such Business Combination
(including, without limitation, a corporation which as a result of such
transaction owns the Company or all or substantially all of the Company’s assets
either directly or through one or more subsidiaries) in substantially the same
proportions as their ownership, immediately prior to such Business Combination
of the Outstanding Company Common Stock and Outstanding Company Voting
Securities, as the case may be, (ii) no Person (excluding any employee benefit
plan (or related trust) of the Company or such corporation resulting from such
Business Combination) beneficially owns, directly or indirectly, thirty percent
(30%) or more of, respectively, the then outstanding shares of common stock of
the corporation resulting from such Business Combination or the combined voting
power of the then outstanding voting securities of such corporation except to
the extent that such ownership existed prior to the Business Combination, and
(iii) at least a majority of the members of the board of directors of the
corporation resulting from such Business Combination were members of the
Incumbent Board at the time of the execution of the initial agreement, or of the
action of the Board, providing for such Business Combination; or

 

(d)                                 Approval by the shareholders of the Company
of a complete liquidation or dissolution of the Company.

 

3.                                       Compensation Upon Certain Terminations
of Employment Following a Change of Control.  In the event the Executive’s
employment is terminated or Constructively Terminated by reason of Change of
Control that occurs during the Change of Control Period, the following shall be
applicable:

 

3

--------------------------------------------------------------------------------

 

(a)                                  The Executive shall be entitled to receive,
at her option, either (i) a lump sum cash payment equal to one (1) times the
Executive’s annual base salary, which shall be due within thirty (30) days after
the Date of Termination or (ii) twelve (12) equal monthly installments which in
aggregate shall be equal to one (1) times the Executive’s annual base salary,
the first payment of which shall be due within thirty (30) days after the Date
of Termination.  For purposes of this Agreement, “annual base salary” shall mean
one (1) year of base salary, at the highest base salary rate that Executive was
paid by the Company in the twelve (12) months prior to the Date of Termination
(the “Look Back Period”).

 

(b)                                 The Company shall continue to pay any health
insurance benefits as were provided to Executive and his family under the plans
of the Company as of the Change of Control for a period of twelve (12) months
following the Date of Termination.

 

(c)                                  All outstanding stock options previously
granted under any Company stock option plan, whether vested or unvested, shall
be accelerated and become immediately exercisable for a period of six (6) months
after the Date of Termination.

 

(d)                                 Notwithstanding the foregoing, the Company
shall have no obligation to make any payment or offer any benefits under this
Section 3 if the Executive’s employment is terminated for Cause, death,
Disability, retirement or resignation other than for good reason following a
Change of Control.

 

4.                                       Non-Exclusivity of Rights.  Nothing in
this Agreement shall prevent or limit the Executive’s continuing or future
participation in any plan, practice, policy or program provided by the Company
or any of its affiliated companies and for which the Executive may qualify, nor
shall anything herein limit or otherwise affect such rights as the Executive may
have under any contract or agreement with the Company or any of its affiliated
companies.  Amounts which are vested benefits or which the Executive is
otherwise entitled to receive under any plan, policy, practice or program of or
any contract or agreement with the Company or any of its affiliated companies at
or subsequent to the Date of Termination shall be payable in accordance with
such plan, practice, policy or program or contract or agreement except as
explicitly modified by this Agreement.

 

5.                                       Full Settlement.  The Company’s
obligation to make the payments provided for in this Agreement and otherwise to
perform its obligations hereunder shall not be affected by any set-off,
counterclaim, recoupment, defense or other claim, right or action which the
Company may have against the Executive or others.

 

6.                                       Duty to Mitigate.  In no event shall
the Executive be obligated to seek other employment or take any other action by
way of mitigation of the amounts payable to the Executive under any of the
provisions of this Agreement and such amounts shall not be reduced whether or
not the Executive obtains other employment.

 

4

--------------------------------------------------------------------------------

 

7.                                       Fees and Expenses.  The Company agrees
to pay as incurred, to the full extent permitted by law, all legal fees and
expenses which the Executive may reasonably incur as a result of any contest
(regardless of the outcome thereof) by the Company, the Executive or others of
the validity or enforceability of, or liability under, any provision of this
Agreement or any guarantee of performance thereof (including as a result of any
contest by the Executive about the amount of any payment pursuant to this
Agreement), plus in each case interest on any delayed payment at the applicable
Federal rate provided for in Section 7872(f)(2)(A) of the Internal Revenue Code
of 1986, as amended (the “Code”).

 

8.                                       Tax.

 

(a)                                  The Company shall have no liability for any
tax liability of Executive attributable to any payments made under this
Agreement.  The Company may withhold from any amounts payable under this
Agreement such Federal, state, local or foreign taxes as shall be required to be
withheld pursuant to any applicable law or regulation.

 

(b)                                 Anything in this Agreement to the contrary
notwithstanding, (1) in the event that any payment to or for the Executive’s
benefit (whether payable pursuant to the terms of this Agreement or otherwise)
would not be deductible by the Company as a result of Section 280G of the Code
then the aggregate amount payable under Section 3 shall be reduced (but not
below zero dollars), so that after giving effect to such reduction, no payment
made to or for the Executive’s benefit will fail to be deductible because of
Section 280G, and (2) if the Executive establishes (in accordance with
Section 280G) that all or any portion of the aggregate “parachute payments” (as
defined in Section 280G) payable to or for the Executive’s benefit constitute
reasonable compensation for services actually rendered, and if the present value
of all such “parachute payments” which constitute reasonable compensation
exceeds two hundred ninety-nine percent (299%) of the Executive’s “base amount”
(as defined in Section 280G), then the Executive shall be entitled to receive an
amount equal to (but not greater than) the present value of all such “parachute
payments” which constitute reasonable compensation.  For purposes of this
Section 8(b), the “present value” of any payment shall be determined in
accordance with Section 1274(b)(2) of the Code.  If it is established that,
notwithstanding the good faith of the Executive and the Company in applying the
terms of this Section 8(b), the aggregate “parachute payments” paid to or for
the Executive’s benefit are in an amount that would result in any portion of
such “parachute payments” not being deductible, then the Executive shall have an
obligation to pay the Company upon demand an amount equal to the sum of (1) the
excess of the aggregate “parachute payments” paid to or for the Executive’s
benefit over the aggregate “parachute payments” that could have been paid to or
for the Executive’s benefit without any portion of such “parachute payments” not
being deductible; and (2) interest on the amount set forth in clause (1) of this
sentence at the applicable federal rate (as defined in Section 1274(d) of the
Code) from the date of the receipt of such excess by or for the Executive’s
behalf until the date of such payment.

 

5

--------------------------------------------------------------------------------

 

9.                                       Successors.

 

(a)                                  This Agreement is personal to the Executive
and without the prior written consent of the Company shall not be assignable by
the Executive otherwise than by will or the laws of descent and distribution. 
This Agreement shall inure to the benefit of and be enforceable by the
Executive’s legal representatives.

 

(b)                                 This Agreement shall inure to the benefit of
and be binding upon the Company and its successors and assigns.

 

(c)                                  The Company will require any successor
(whether direct or indirect, by purchase, merger, consolidation or otherwise) to
all or substantially all of the business and/or assets of the Company to assume
expressly and agree to perform this Agreement in the same manner and to the same
extent that the Company would be required to perform it if no such succession
had taken place.  As used in this Agreement, “Company” shall mean the Company as
hereinbefore defined and any successor to its business and/or assets as
aforesaid.

 

10.                                 Miscellaneous.

 

(a)                                  Choice of Law.  This Agreement shall be
governed by and construed in accordance with the laws of the State of
California, without reference to principles of conflict of laws.  The captions
of this Agreement are not part of the provisions hereof and shall have no force
or effect.  This Agreement may not be amended or modified otherwise than by a
written agreement executed by the parties hereto or their respective successors
and legal representatives.

 

(b)                                 Notices. All notices and other
communications hereunder shall be in writing and shall be given by hand delivery
to the other party or by registered or certified mail, return receipt requested,
postage prepaid, addressed as follows:

 

If to the Executive:

Robert S. Chilton

21101 Oxnard Street

Woodland Hills, California 91367

 

If to the Company:

 

HemaCare Corporation
21101 Oxnard Street
Woodland Hills, California 91367
Phone: 877-310-0717 • Fax: 818-251-5300

 

or to such other address as either party shall have furnished to the other in
writing in accordance herewith.  Notice and communications shall be effective
when actually received by the addressee.

 

6

--------------------------------------------------------------------------------

 

(c)                                  Validity.  The invalidity or
unenforceability of any provision of this Agreement shall not affect the
validity or enforceability of any other provision of this Agreement.

 

(d)                                 Headings.  All captions and section headings
used in this Agreement are for convenient reference only and do not forma part
of this Agreement.

 

(e)                                  Waiver.  No provision of this Agreement
shall be modified, waived or discharged unless such modification, waiver or
discharge is agreed to and signed in writing by Executive and an authorized
officer of the Company (other than Executive).

 

(f)                                    Counterparts.  This Agreement may be
executed in counterparts, each of which shall be deemed an original, but all of
which together will constitute one and the same instrument.

 

[Remainder of page left blank intentionally.]

 

7

--------------------------------------------------------------------------------

 

IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and,
pursuant to the authorization from its Board of Directors, the Company has
caused these presents to be executed in its name on its behalf, all as of the
day and year first above written.

 

 

 

HemaCare Corporation

 

 

 

 

 

 

 

By:

/s/ Judi Irving

 

 

Name:

Judi Irving

 

 

Title:

President and Chief Executive Officer

 

 

 

 

 

 

 

 

Executive

 

 

 

 

By:

/s/ Robert S. Chilton

 

 

Name:

Robert S. Chilton

 

 

Title:

Executive Vice President and Chief

 

 

 

Financial Officer

 

 

8

--------------------------------------------------------------------------------